Standard BioTools GAAP EPS of -$0.09 misses by $0.03, revenue of $19.55M beats by $1.55M
Source: SeekingAlpha
2025-11-04 16:43:12 ET
- Standard BioTools press release ( LAB ): Q3 GAAP EPS of -$0.09 misses by $0.03 .
- Revenue of $19.55M (-56.5% Y/Y) beats by $1.55M .
- For fiscal year 2025, the Company continues to expect combined revenue in the range of $165 million to $175 million. Revenue from continuing operations is expected to be in the range of $78 million to $83 million.
Read the full article on Seeking Alpha
For further details see:
Standard BioTools GAAP EPS of -$0.09 misses by $0.03, revenue of $19.55M beats by $1.55M
Standard BioTools Inc.
NASDAQ: LAB
LAB Trading
0.16% G/L:
$0.9336 Last:
1,106,612 Volume:
$0.94 Open:
LAB Latest News
February 24, 2026 04:10:00 pm
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results
LAB Stock Data
$476,861,113
295,500,064
21.04%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
